CLINICAL INVESTIGATIONS OF SULBACTAM/CEFOPERAZONE

Abstract

Sulbactam/Cefoperazone, a new antibiotic formulation consisting of sulbactam plus cefoperazone, was administered to 7 patients with various infections diseases, which were failed to be cured with cephems or aminoglycosides. Sulbactam/Cefoperazone was given by I. V. D. infusion at a daily dose of 2-4g for 5-21 days. Clinical efficacy was excellent in 1, good in 4, fair in 1 and poor in 1 case.
No adverse effect was observed.